Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
Crossref DOI link: https://doi.org/10.1007/s11684-016-0472-9
Published Online: 2016-12-23
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Du, Xin
Zhou, Daobin
License valid from 2016-12-01